An In Vitro Study For Bioequivalence Of New Formulation (Ibuprofen) - Anny, Sharmin Akter;Jamal, Ishrat;Paul, Niloy
26,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
13 °P sammeln
  • Broschiertes Buch

Cost efficiency is a very critical term for formulating a commodity. With a low price, people will get decent quality and they would like the quality. Bioequivalence monitoring must be required for the creation of a medication to ensure the clinical performance of medicines that have experienced improvements in processing processes as well as in formulation modifications. Here, we tried to create a cost-effective formulation of Ibuprofen tablets (400 mg) so that people could use it safely at a low price. The release profile, similarity factor (f2) and mechanical properties of the Ibuprofen…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Cost efficiency is a very critical term for formulating a commodity. With a low price, people will get decent quality and they would like the quality. Bioequivalence monitoring must be required for the creation of a medication to ensure the clinical performance of medicines that have experienced improvements in processing processes as well as in formulation modifications. Here, we tried to create a cost-effective formulation of Ibuprofen tablets (400 mg) so that people could use it safely at a low price. The release profile, similarity factor (f2) and mechanical properties of the Ibuprofen tablets were also evaluated. Thus, owing to the low price of high quality excipients, this current formulation may be a better advertised commodity with at least one third lower prices.
Autorenporträt
Sharmin Akter Anny, Ishrat Jamal, and Niloy Paul have completed Master of Pharmacy from the Department of Pharmacy, Daffodil International University. They currently work at the Technology Lab, Department of Pharmacy, and doing research in different types of formulations.